Compare 10X Genomics Inc (TXG) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Western Alliance Bancorporation — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while Western Alliance Bancorporation trades at $79.8 (market cap $8.84B). The key difference: Western Alliance Bancorporation is the larger of the two by market cap, and Western Alliance Bancorporation pays a 2.07% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | WAL | |
|---|---|---|
Market Cap | $5.48B | $8.84B |
Sector | Health | Financials |
52-Week High | $45.80 | $96.08 |
52-Week Low | $11.34 | $66.70 |
Enterprise Value | $5.02B | — |
Dividend Yield | — | 2.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
